Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer

Breast Cancer Research and Treatment

Volumn 53, Issue 1, 1999, Pages 9-17

  Silva, Jose M ^a   Gonzalez, Rocio ^a   Provencio, Mariano ^a   Dominguez, Gema ^a   Garcia, Jose M ^a   Gallego, Isabel ^b   Palacios, Jose ^c   España, Pilar ^a   Bonilla, Felix ^a,d  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Clinica del Trabajo   (Spain)

Author keywords

13q12 13 region; 17q21 region; Breast cancer; Microsatellites; Prognostic factors

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CHROMOSOME 13Q; CHROMOSOME 17Q; FEMALE; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENES, BRCA1; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSCRIPTION FACTORS;

EID: 0032973646     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006082117266     Document Type: Article

References (32)

1. Weinberg RA: Tumor suppressor genes. Science 254: 1138-1146, 1991
2. Radford DM, Phillips NJ, Fair KL, Ritter HH, Holt M, Donis-Keller H: Allelic loss and progression of breast cancer. Cancer Res 55: 5180-5183, 1995
3. Skirnisdottir S, Eiriksdottir G, Baldursson T, Barkardottir RB, Egilsson V, Ingvarsson S: High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: Correlation with high PgR and low S phase. Int J Cancer 64: 112-116, 1995
4. Deng G, Lu Y, Flotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059, 1996
5. Patel U, Grundfest-Broniatowski S, Gupta M, Banerjee S: Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 9: 3695-3700, 1994
6. Chen L-C, Neubauer A, Kurisu W, Waldman FM, Ljung B-M, Goodson W III, Goldman ES, Moore D II, Balazs M, Liu E, Mayall BH, Smith HS: Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci USA 88: 3847-3851, 1991
7. Zenklusen JC, Bieche I, Lidereau R, Conti CJ: (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 91: 12155-12158, 1994
8. Friedman LS, Ostermeyer EA, Lynch ED, Szabo CI, Anderson LA, Dowd P, Lee MK, Rowell SE, Boyd F, King M-C: The search for BRCA1. Cancer Res 54: 6374-6382, 1994
9. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990
10. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir G, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090, 1994
11. Szabo CI, King M-C: Inherited breast and ovarian cancer. Hum Mol Genet 4: 1811-1817, 1995
12. Kellsell DP, Spurr NK, Barnes DM, Gusterson B, Bishop DT: Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347: 1554-1555, 1996
13. Beckmann MW, Picard F, An HX, van Roeyen CRC, Dominik SI, Mosny DS, Schnurch HG, Bender HG, Niederacher D: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220-1226, 1996
14. van der Berg J, Johannsson O, Hakansson S, Olsson H, Borg A: Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74: 1615-1619, 1996
15. Cleton-Jansen A-M, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR: Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 72: 1241-1244, 1995
16. Paulson TG, Wright FA, Parker BA, Russack V, Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996
17. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT: Hereditary breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77: 697-709, 1996
18. Porter DE, Dixon M, Smyth E, Steel CM: Breast cancer survival in BRCA1 carriers. Lancet 341: 184-185, 1993
19. Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, Livolsi VA, Berchuck A, Muto MG, Garber JE, Weber BL, Lynch HT, Boyd J: Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335: 1413-1416, 1996
20. Garcia-Patiño E, Gomendio B, Provencio M, Silva JM, Garcia JM, España P, Bonilla F: Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations. J Clin Oncol 16: 115-120, 1998
21. Oto M, Miyake S, Yuasa Y: Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Ann Biochem 213: 19-22, 1993
22. Borg A, Zhang QX, Alm P, Olsson H, Sellberg G: The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991-2994, 1992
23. Tsukamoto K, Ito N, Yoshimoto M, Iwase T, Tada T, Kasumi F, Nakamura Y, Emi M: Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas. Cancer 78: 1929-1934, 1996
24. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoof R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA: BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13: 238-240, 1996
25. Teng DH-F, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AKC, Kamb A: Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 13: 241-244, 1996
26. Miki Y, Katagiri T, Kasumi F, Yoshimoto T, Nakamura Y: Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 13: 245-247, 1996
27. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton D, Ponder BAJ: Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336: 1125-1130, 1997
28. Marcus JN, Page DL, Watson P, Narod SA, Lenoir GM, Lynch HT: BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 80: 543-556, 1997
29. Harris JR, Morrow M, Norton L: Malignant tumors of the breast. In: DeVita VT, Hellman S, Rosenberg SA (eds), Cancer Principles and Practice of Oncology. Lippincott-Noreu, Philadelphia, 5th Edition, Vol 2, 1997, pp 1557-1616
30. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275, 1997
31. Sharan SK, Morimatsu M, Albrecht U, Lim D-S, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 386: 804-810, 1997
32. Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD: Cell cycle control of BRCA2. Cancer Res 56: 4590-4594, 1996